Skip to Content
Merck
CN

V800000

1,10-Phenanthroline hydrochloride monohydrate

Vetec™, reagent grade

Synonym(s):

o-Phenanthroline hydrochloride monohydrate

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C12H8N2 · HCl · H2O
CAS Number:
18851-33-7
Molecular Weight:
234.68
UNSPSC Code:
12352300
PubChem Substance ID:
329829064
EC Number:
200-629-2
Beilstein/REAXYS Number:
4007967
MDL number:
MFCD00150061
Grade:
reagent grade

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

1,10-Phenanthroline hydrochloride monohydrate, Vetec™, reagent grade

InChI key

NDLHUHRGAIHALB-UHFFFAOYSA-N

InChI

1S/C12H8N2.ClH.H2O/c1-3-9-5-6-10-4-2-8-14-12(10)11(9)13-7-1;;/h1-8H;1H;1H2

SMILES string

O.Cl.c1cnc2c(c1)ccc3cccnc23

grade

reagent grade

product line

Vetec™

mp

224-225 °C (lit.)

Looking for similar products? Visit Product Comparison Guide

Legal Information

Vetec is a trademark of Merck KGaA, Darmstadt, Germany

pictograms

Skull and crossbonesEnvironment
GHS06,GHS09

signalword

Danger

hcodes

H301,H410

Hazard Classifications

Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 1

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

T M-H Nguyen et al.
International journal of pharmaceutics, 482(1-2), 21-26 (2014-12-03)
Hyperphosphatemia is one of the main risk factors contributing to morbidity and mortality in patients with end stage renal disease. The demand for a new phosphate binder is continuously increasing since the number of patients suffering under hyperphosphatemia is growing.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service